Arkadios Wealth Advisors Eli Lilly & CO Transaction History

Arkadios Wealth Advisors

$1.4 Billion
Q2 2024

A detailed history of Arkadios Wealth Advisors transactions in Eli Lilly & CO stock. As of the latest transaction made, Arkadios Wealth Advisors holds 5,452 shares of LLY stock, worth $4.78 Million. This represents 0.35% of its overall portfolio holdings.

Number of Shares

5,452

Previous 3,911 39.4%

Holding current value

$4.78 Million

Previous $3.04 Million 62.26%

% of portfolio

0.35%

Previous 0.25%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 29, 2024	BUY	$724.87 - $909.04 $1.12 Million - $1.4 Million	1,541 Added 39.4%	5,452 $4.94 Million
Q1 2024 Apr 30, 2024	BUY	$592.2 - $792.28 $63,365 - $84,773	107 Added 2.81%	3,911 $3.04 Million
Q4 2023 Jan 24, 2024	SELL	$525.19 - $619.13 $60,922 - $71,819	-116 Reduced 2.96%	3,804 $2.22 Million
Q3 2023 Oct 13, 2023	BUY	$434.7 - $599.3 $599,886 - $827,033	1,380 Added 54.33%	3,920 $2.11 Million
Q2 2023 Jul 26, 2023	SELL	$350.74 - $468.98 $118,900 - $158,984	-339 Reduced 11.77%	2,540 $1.19 Million
Q1 2023 May 02, 2023	BUY	$310.63 - $364.82 $190,726 - $223,999	614 Added 27.11%	2,879 $988,000
Q4 2022 Jan 11, 2023	SELL	$321.55 - $374.67 $39,550 - $46,084	-123 Reduced 5.15%	2,265 $0
Q3 2022 Oct 21, 2022	SELL	$296.48 - $337.87 $7,412 - $8,446	-25 Reduced 1.04%	2,388 $772,000
Q2 2022 Jul 14, 2022	SELL	$278.73 - $327.27 $60,484 - $71,017	-217 Reduced 8.25%	2,413 $782,000
Q1 2022 May 02, 2022	SELL	$234.69 - $291.66 $144,803 - $179,954	-617 Reduced 19.0%	2,630 $753,000
Q4 2021 Feb 03, 2022	BUY	$224.85 - $279.04 $41,822 - $51,901	186 Added 6.08%	3,247 $897,000
Q3 2021 Oct 19, 2021	SELL	$221.6 - $272.71 $104,152 - $128,173	-470 Reduced 13.31%	3,061 $707,000
Q2 2021 Jul 28, 2021	SELL	$180.55 - $233.54 $202,757 - $262,265	-1,123 Reduced 24.13%	3,531 $810,000
Q1 2021 Apr 26, 2021	BUY	$164.32 - $212.72 $501,997 - $649,859	3,055 Added 191.06%	4,654 $869,000
Q4 2020 Feb 09, 2021	BUY	$130.46 - $172.63 $141,549 - $187,303	1,085 Added 211.09%	1,599 $270,000
Q3 2020 Nov 10, 2020	BUY	$146.22 - $169.13 $1,169 - $1,353	8 Added 1.58%	514 $75.1 Million
Q2 2020 Aug 10, 2020	SELL	$136.42 - $164.18 $3,137 - $3,776	-23 Reduced 4.35%	506 $83 Million
Q1 2020 May 14, 2020	SELL	$119.05 - $147.35 $18,690 - $23,133	-157 Reduced 22.89%	529 $73.3 Million
Q4 2019 Feb 14, 2020	BUY	$106.92 - $132.43 $73,347 - $90,846	686 New	686 $90,000

Others Institutions Holding LLY

# of Institutions

3,872

Shares Held

751M

Call Options Held

6.34M

Put Options Held

7.97M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $834B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Arkadios Wealth Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Arkadios Wealth Advisors with notifications on news.

Account

Arkadios Wealth Advisors Eli Lilly & CO Transaction History